Reaction
Bone Swelling reporting signals
As of the last recalculation, Bone Swelling appears in 961 FAERS reports alongside 20 co-occurring drug terms. The strongest observed disproportionality signal is CHLORHEXIDINE GLUCONATE (PRR 50.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Chlorhexidine Gluconate | 21 | 50.9 | 51.0 |
| Tofacitinib Citrate | 27 | 45.9 | 46.0 |
| Sulfasalazine | 84 | 25.4 | 25.4 |
| Leflunomide | 109 | 25.3 | 25.3 |
| Exemestane | 23 | 23.8 | 23.8 |
| Bicalutamide | 15 | 21.6 | 21.7 |
| Melphalan | 22 | 21.4 | 21.4 |
| Hydroxychloroquine | 67 | 20.8 | 20.8 |
| Celecoxib | 111 | 20.5 | 20.5 |
| Melphalan Hydrochloride | 23 | 20.3 | 20.3 |
| Methylprednisolone Acetate | 7 | 19.1 | 19.1 |
| Abatacept | 99 | 17.1 | 17.2 |
| Goserelin | 9 | 14.6 | 14.7 |
| Zoledronic Acid | 24 | 13.3 | 13.3 |
| Tocilizumab | 62 | 12.5 | 12.5 |
| Thalidomide | 18 | 10.8 | 10.8 |
| Tofacitinib | 70 | 8.8 | 8.8 |
| Fesoterodine Fumarate | 4 | 8.0 | 8.0 |
| Golimumab | 30 | 7.8 | 7.8 |
| Emicizumab | 3 | 5.3 | 5.3 |